Evidence map›Paper›PMID 38926759›Full record

ArticleBMC biology2024

Deletion of VPS50 protein in mouse brain impairs synaptic function and behavior.

Constanza Ahumada-Marchant, Carlos Ancatén-Gonzalez, Henny Haensgen, Bastian Brauer, Nicolas Merino-Veliz, Rita Droste, Felipe Arancibia, H Robert Horvitz, Martha Constantine-Paton, Gloria Arriagada and 2 more

Abstract read
In one paragraph

Article in BMC biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Constanza Ahumada-MarchantConstantine-Paton Research Laboratory, Institute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Carlos Ancatén-GonzalezPrograma de Doctorado en Ciencias, Universidad de Valparaíso, Mención Neurociencia, Valparaíso, Chile.
Henny HaensgenConstantine-Paton Research Laboratory, Institute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Bastian BrauerConstantine-Paton Research Laboratory, Institute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Nicolas Merino-VelizConstantine-Paton Research Laboratory, Institute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Rita DrosteDepartment of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, McGovern Institute for Brain Research, Cambridge, MA, 02139, USA.
Felipe ArancibiaConstantine-Paton Research Laboratory, Institute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
H Robert HorvitzDepartment of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, McGovern Institute for Brain Research, Cambridge, MA, 02139, USA.
Martha Constantine-PatonDepartment of Biology, Massachusetts Institute of Technology, McGovern Institute for Brain Research, Cambridge, MA, 02139, USA.
Gloria ArriagadaConstantine-Paton Research Laboratory, Institute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile.
Andrés E ChávezInstituto de Neurociencias, Centro Interdisciplinario de Neurociencia de Valparaíso (CINV), Facultad de Ciencias, Universidad de Valparaíso, Valparaíso, Chile.
Fernando J BustosConstantine-Paton Research Laboratory, Institute of Biomedical Sciences (ICB), Faculty of Medicine and Faculty of Life Sciences, Universidad Andres Bello, Santiago, Chile. fernando.bustos@unab.cl.ORCID http://orcid.org/0000-0002-0487-7032

Funding

Genetic Analysis of Nematode Egg Laying and Co-regulated Behavioral SystemsR01GM024663 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HORVITZ, H ROBERT · 1985 to 2025
$10.1M
Glutamate Receptor Trafficking in Visual DevelopmentR03EY014420 · NEI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CONSTANTINE-PATON, MARTHA · 2003 to 2005
$489k
Agencia Nacional de Investigación y Desarrollo ANID-MILENIO (NCN2023_23)Agencia Nacional de Investigación y Desarrollo Exploración-ANID 13220203Agencia Nacional de Investigación y Desarrollo Fondecyt Iniciación 11180540Agencia Nacional de Investigación y Desarrollo FONDECYT Regular #1201848Agencia Nacional de Investigación y Desarrollo FONDECYT Regular # 1220480Agencia Nacional de Investigación y Desarrollo Fondequip # EQM160154Agencia Nacional de Investigación y Desarrollo PAI 77180077NEI NIH HHS R01-EY014420NEI NIH HHS R03 EY014420NIGMS NIH HHS R01 GM024663NIGMS NIH HHS R01-GM024663Universidad Andrés Bello UNAB DI-02-22/REG
6 · The paper itself

Abstract

backgroundThe VPS50 protein functions in synaptic and dense core vesicle acidification, and perturbations of VPS50 function produce behavioral changes in Caenorhabditis elegans. Patients with mutations in VPS50 show severe developmental delay and intellectual disability, characteristics that have been associated with autism spectrum disorders (ASDs). The mechanisms that link VPS50 mutations to ASD are unknown.

resultsTo examine the role of VPS50 in mammalian brain function and behavior, we used the CRISPR/Cas9 system to generate knockouts of VPS50 in both cultured murine cortical neurons and living mice. In cultured neurons, KO of VPS50 did not affect the number of synaptic vesicles but did cause mislocalization of the V-ATPase V1 domain pump and impaired synaptic activity, likely as a consequence of defects in vesicle acidification and vesicle content. In mice, mosaic KO of VPS50 in the hippocampus altered synaptic transmission and plasticity and generated robust cognitive impairments.

conclusionsWe propose that VPS50 functions as an accessory protein to aid the recruitment of the V-ATPase V1 domain to synaptic vesicles and in that way plays a crucial role in controlling synaptic vesicle acidification. Understanding the mechanisms controlling behaviors and synaptic function in ASD-associated mutations is pivotal for the development of targeted interventions, which may open new avenues for therapeutic strategies aimed at ASD and related conditions.

Indexed as

Mice, KnockoutSynaptic VesiclesAnimalsBehavior, AnimalBrainMiceNeuronsSynapsesSynaptic TransmissionVacuolar Proton-Translocating ATPasesVesicular Transport ProteinsVacuolar Proton-Translocating ATPasesVesicular Transport ProteinsVps50 protein, mouseASDGene editingSynaptic vesiclesVesicle acidificationVPS50

Identifiers

PMID38926759
PMCPMC11210182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.